A Peek into a Plausible Cool Future: Genome Editing to Delete PCSK9 and Control Hypercholesterolemia in a Single Shot

por Fazio, Sergio, Tavori, Hagai
Publicado 2014

HDL Particle Size and Functional Heterogeneity

por Fazio, Sergio, Pamir, Nathalie
Publicado en Circ Res (2016)

Lipoprotein(a) gets worse

por Pamir, Nathalie, Fazio, Sergio
Publicado en Circ Res (2020)

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease

por Shapiro, Michael D., Fazio, Sergio
Publicado en F1000Res (2017)

PCSK9 and Atherosclerosis - Lipids and Beyond

por Shapiro, Michael D., Fazio, Sergio
Publicado en J Atheroscler Thromb (2017)

The American journal of preventive cardiology: On a mission to help define a specialty

por Fazio, Sergio, Wong, Nathan D.
Publicado en Am J Prev Cardiol (2020)

Preventive cardiology as a dedicated clinical service: The past, the present, and the (Magnificent) future

por Shapiro, Michael D., Fazio, Sergio
Publicado en Am J Prev Cardiol (2020)

Medication-based vs. Target-based Lipid Management

por FAZIO, Sergio, SHAPIRO, Michael D.
Publicado en J Diabetes (2018)

Lipoprotein(a): An Enigmatic Sheep in the Lipoprotein Herd

por Shapiro, Michael D., Fazio, Sergio
Publicado en JACC Basic Transl Sci (2020)

Editors’ page

por Fazio, Sergio, Wong, Nathan D.
Publicado en Am J Prev Cardiol (2020)

PREVENTIVE CARDIOLOGY AS NEW SUBSPECIALTY OF CARDIOVASCULAR MEDICINE

por FAZIO, SERGIO, SHAPIRO, MICHAEL D.
Publicado en Trans Am Clin Climatol Assoc (2020)

Editors’ Page

por Fazio, Sergio, Wong, Nathan D.
Publicado en Am J Prev Cardiol (2020)

Editors’ page

por Fazio, Sergio, Wong, Nathan D.
Publicado en Am J Prev Cardiol (2020)

Debate: "How low should LDL cholesterol be lowered?" Viewpoint: "It doesn't need to be very low"

por Fazio, Sergio, Linton, MacRae F
Publicado 2001

Cyclooxygenase products and atherosclerosis

por Linton, MacRae F., Fazio, Sergio
Publicado 2008

Elevated High-Density Lipoprotein (HDL) Levels due to Hepatic Lipase Mutations Do Not Reduce Cardiovascular Disease Risk: Another Strike against the HDL Dogma

por Fazio, Sergio, Linton, MacRae F.
Publicado 2009

6-Mercaptopurine, Monocytes and Atherosclerosis

por Linton, MacRae F., Fazio, Sergio
Publicado 2010

Killing Two Birds With One Stone, Maybe: CETP Inhibition Increases Both High-Density Lipoprotein Levels and Insulin Secretion

por Fazio, Sergio, Linton, MacRae F.
Publicado 2013

PCSK9 inhibition to reduce cardiovascular disease risk: recent findings from the biology of PCSK9

por Tavori, Hagai, Giunzioni, Ilaria, Fazio, Sergio
Publicado en Curr Opin Endocrinol Diabetes Obes (2015)

On the Function and Homeostasis of PCSK9: Reciprocal Interaction with LDLR and Additional Lipid Effects

por Tavori, Hagai, Rashid, Shirya, Fazio, Sergio
Publicado en Atherosclerosis (2014)